Search
for
Sort by
Research 391–420 of 1000+
- Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice
- The Effect of a Very-Low-Calorie Diet (VLCD) vs. a Moderate Energy Deficit Diet in Obese Women with Polycystic Ovary Syndrome (PCOS)—A Randomised Controlled Trial
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review
- The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial
- Endocrinology of Transgender Medicine
- Testosterone therapy for transgender men
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Psychoactive drugs and skin
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail
- Light Pollution and Oxidative Stress: Effects on Retina and Human Health
- Sex Differences in Opioid-Mediated Effects: Role of Androgens
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Effects of photobiomodulation on multiple health outcomes: an umbrella review of randomized clinical trials
- Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature
- Effect of zinc, ferritin, and vitamin B12 deficiency on hair loss in pregnant women
- Epigenetic regulation and factors that influence the effect of iPSCs-derived neural stem/progenitor cells (NS/PCs) in the treatment of spinal cord injury
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Vitamin D Adequacy Conditions the Prolactin-Suppressive Effect of Metformin in Men Receiving Prolactin-Elevating Medications
- The COVID-19 pandemic and its skin effects
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects